About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials in Phoenix | 52 Studies

Clinical Trials COVID-19Phoenix

COVID-19 Clinical Trials in Phoenix

Find 52 clinical trials for covid-19 near Phoenix, Arizona. Connect with research centers in your area.

All COVID-19 trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-52 of 52 trials

CompletedA Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2This is a phase 3, randomized, observer-blinded, placebo-controlled study to evaluate the efficacy, safety, and immunogenicity of SARS-CoV-2 rS with Matrix-M1 adjuvant in adult…NCT04611802·Birmingham, Alabama and 153 others

COVID-19 Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Approved for marketingExpanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)The primary objective of this study is to provide expanded access of remdesivir (RDV) for the treatment of severe acute respiratory syndrome coronavirus (SARS-CoV2) infection.NCT04323761·Birmingham, Alabama and 271 others

RecruitingEPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe DiseaseThe purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after…NCT05261139·Phoenix, Arizona and 72 others

CompletedStudy to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy ChildrenThis is a Phase 1/2/3 study in healthy children.NCT04816643·Birmingham, Alabama and 127 others

CompletedRECOVER-ENERGIZE Platform ProtocolThis is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with…NCT06404047·Birmingham, Alabama and 41 others

CompletedA Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine BoostersThe main goal of Part A of this study is to assess the safety, reactogenicity, and immunogenicity of the study vaccine candidates.NCT05137236·Phoenix, Arizona and 16 others

CompletedSafety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19The primary objectives are: Pooled Phase 3 (Cohort 1) and Phase 2 (Cohort 1A) * To evaluate the virologic efficacy of REGN10933+REGN10987 compared to placebo in reducing viral…NCT04426695·Birmingham, Alabama and 122 others

CompletedSafety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)The purpose of this study to evaluate the safety and immunogenicity of a 2-dose regimen of 9vHPV vaccine, where the first dose is administered concomitantly with a first dose of a…NCT05119855·Phoenix, Arizona and 37 others

TerminatedVA CoronavirUs Research and Efficacy Studies-1The purpose of this study is to determine if treatment with convalescent plasma improves the clinical outcomes of Veterans who are hospitalized and require supplemental oxygen due…NCT04539275·Birmingham, Alabama and 23 others

CompletedACTIV-2: A Study for Outpatients With COVID-19Drug studies often look at the effect one or two drugs have on a medical condition, and involve one company.NCT04518410·Anniston, Alabama and 251 others

CompletedComparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza VaccinationsThis is a prospective, randomized randomized immunologic study of response to influenza and SARS-CoV-2 vaccination across four of the US Influenza Vaccine Effectiveness (Flu VE)…NCT06020118·Phoenix, Arizona and 7 others

CompletedA Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19The primary goal for this study is to evaluate the safety and reactogenicity of 3 dose levels of mRNA-1283 and 1 dose level of mRNA-1273 vaccine given to healthy adults in 2…NCT04813796·Chandler, Arizona and 4 others

PreviousPage 3 of 3

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia